Skip to main content
Clinical Trials/NCT01135719
NCT01135719CompletedNot Applicable

A Prospective Randomized Comparison of Fellow Eyes Undergoing LASIK or PRK With a Wavefront-guided Excimer Laser Versus a Wavefront-optimized Excimer Laser

Edward E. Manche2 sites in 1 country137 target enrollmentStarted: April 2009Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
137
Locations
2
Primary Endpoint
Changes in 25 and 5% low contrast visual acuity.

Study Overview

Brief Summary

Subjects with myopia, hyperopia and astigmatism are being randomized to be treated in one eye with a wavefront-guided excimer laser and their fellow eye treated with a wavefront-optimized excimer laser.

Detailed Description

Subjects with myopia, hyperopia and astigmatism are being randomized by ocular dominance to be treated with either PRK or LASIK. One eye will be treated with a wavefront-guided excimer laser and the fellow eye will be treated with a wavefront optimized excimer laser.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
21 Years to 60 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Healthy subjects age 21 and older.
  • Subjects with nearsightedness, farsightedness and/or astigmatism.

Exclusion Criteria

  • Autoimmune diseases.
  • Children.
  • Women pregnant or nursing.
  • Ectatic corneal disease.
  • Previous ocular surgery.

Outcomes

Primary Outcomes

Changes in 25 and 5% low contrast visual acuity.

Time Frame: One year

Improvement in uncorrected visual acuity

Time Frame: One year

Changes in best spectacle corrected visual acuity.

Time Frame: One year

Secondary Outcomes

  • Changes in higher order aberrations.(One year)
  • Topographic changes.(One year)
  • Quality of vision changes.(One year)

Investigators

Sponsor
Edward E. Manche
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Edward E. Manche

Stanford University School of Medicine

Stanford University

Study Sites (2)

Loading locations...

Similar Trials